Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 5 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Mersana Therapeutics Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a 224.07% increase from the last price of 2.16.
High | 316.7% | 9.00 |
Med | 224.1% | 7.00 |
Low | 38.9% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | +13.70% |
Average growth rate | -36.72% |
More ▼
Revenue history & estimates in USD
Average growth rate | -19.38% |
Average growth rate | +15,390.52% |
More ▼